ESG Report 2025

112 11.2 Supporting Education The United Laboratories has long been committed to the field of medical education. Since 1998, the "United Medical Education Scholarship" was established by the Group's founder, Mr. Choy Kam Lok, to provide ongoing support for the development of medical talent in the country. Over the years, this public welfare program has supported more than 50 higher education institutions, with total donations approaching RMB50 million. At the same time, the Group has actively deepened technical exchanges and talent collaboration with universities and colleges. Through industry-academia interaction, it has strengthened university-enterprise linkages, not only promoting the integrated development of education and industry but also laying a solid foundation for building a stable talent pipeline for the Group. The Group continues to promote the integration of industry, academia, and research, supporting the development of pharmaceutical talent in the Greater Bay Area. In May 2025, Zhuhai United Laboratories Co., Ltd. hosted a visit for over 90 faculty members and students from the Faculty of Pharmacy of Macau University of Science and Technology. During the visit, the group toured the Group's modern exhibition hall and intelligent production workshops, gaining insight into the pharmaceutical enterprise's development history, core business operations, and advanced technologies. The Group's human resources team and research staff from United Laboratories Biomedical shared industry experience, technological innovation, and career development topics with the students, offering the younger generation of pharmacy students an opportunity to engage directly with industry practice. The Group recognises that the future of the pharmaceutical industry depends on the participation of talented individuals. This type of exchange not only allows students to observe the operations and responsibilities of a pharmaceutical company firsthand but also helps inspire their enthusiasm and sense of purpose in pharmaceutical research. This event reflects the Group's ongoing commitment to supporting pharmaceutical education and cultivating new talent for the industry, while also laying the groundwork for deeper university-enterprise collaboration and building a pharmaceutical research ecosystem in the Greater Bay Area. Looking ahead, the Group will continue to uphold its principle of open collaboration, welcoming more young students to The United Laboratories and working together to contribute to the advancement of the pharmaceutical industry. Campus-Enterprise Talent Development 11.3 Volunteer Care Caring for communities and responding to local needs is a key pathway through which the Group implements sustainable development. The Group has always regarded the communities surrounding its subsidiaries and production bases as key stakeholders, maintaining long-term and stable connections with them. In the healthcare field, the Group not only continues to invest in pharmaceutical research and development and accessibility, working to improve the availability of medicines, but also actively mobilises employees to participate in community blood donation activities, supporting those in need through concrete action. The Group believes that corporate growth is nurtured by the community, and giving back to the community while safeguarding health is a tangible reflection of the Group's fulfillment of its social responsibilities. 11.3.1 Blood Donation The Group aims to sustain the spirit of "Filial Piety Swallows" through ongoing public welfare work, bringing warmth and care to those in need and offering hope to more communities. The United Laboratories International Holdings Limited 2025 Environmental, Social and Governance Report